5-Chloro-2-methyltriptamine is a derivative of tryptamine known to inhibit in a voltage-dependant manner at the NMDA receptor. Also used in the synthesis of a novel pim-1 kinase competetive inhibitors targeting fluorescently labelled substrate peptides.